Related references
Note: Only part of the references are listed.A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19
M. D. Sadakat Chowdhury et al.
ACADEMIC EMERGENCY MEDICINE (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Rethinking the role of hydroxychloroquine in the treatment of COVID-19
Eric A. Meyerowitz et al.
FASEB JOURNAL (2020)
Hydroxychloroquine prophylaxis for COVID-19 contacts in India
Sahaj Rathi et al.
LANCET INFECTIOUS DISEASES (2020)
Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for Effectiveness
Mahmoud Al-Kofahi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption
E. Takamasu et al.
LUPUS (2019)
Dose escalation of doxepin for intractable pruritus
Kristen M. Beck et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Drug-induced urticarias
P Mathelier-Fusade
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2006)
Share Paper
